Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Colonic Neoplasms

idarubicin has been researched along with Colonic Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's5 (55.56)18.2507
2000's1 (11.11)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, X; Gupte, A; Ledebur, HC; Leggas, M; Ma, P; Mumper, RJ; Swadley, CL1
Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M1
Dandekar, P; Jain, R; Koch, M; Lehr, CM; Loretz, B; Melero, A; Stauner, T; Wenz, G1
Ahmed, T; Arena, F; Cheng, E; Faye, L; Harper, HD; Kemeny, NE; Sordillo, P1
Boiocchi, M; Gigante, M; Simone, F; Toffoli, G1
Baccarani, M; Damiani, D; Lauria, F; Michelutti, A; Michieli, M; Pipan, C; Raspadori, D1
Baccarani, M; Cerno, M; Damiani, D; Melli, C; Michelutti, A; Michieli, M1
Andrew, SM; Foster, HM; Krauer, K; McKenzie, IF; Pietersz, GA; Smyth, MJ; Teh, JG1
Berti, E; Berti, T; Carrara, M; D'Ancona, S; Ragazzi, E1

Other Studies

9 other study(ies) available for idarubicin and Colonic Neoplasms

ArticleYear
Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp-mediated multiple drug resistance in leukemia.
    Journal of biomedical nanotechnology, 2009, Volume: 5, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Resistance, Multiple; Humans; Idarubicin; Leukemia; Lipids; Mice; Mice, Nude; Nanoparticles; Treatment Outcome

2009
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin

2010
Enhanced cellular delivery of idarubicin by surface modification of propyl starch nanoparticles employing pteroic acid conjugated polyvinyl alcohol.
    International journal of pharmaceutics, 2011, Nov-25, Volume: 420, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adsorption; Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Chemistry, Pharmaceutical; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Drug Stability; HT29 Cells; Humans; Idarubicin; Kinetics; Lung Neoplasms; Microscopy, Confocal; Nanoparticles; Nanotechnology; Particle Size; Polyvinyl Alcohol; Protein Binding; Pterins; Solubility; Starch; Surface-Active Agents; Technology, Pharmaceutical

2011
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
    Cancer treatment reports, 1984, Volume: 68, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Colonic Neoplasms; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Rectal Neoplasms

1984
Comparison of mechanisms responsible for resistance to idarubicin and daunorubicin in multidrug resistant LoVo cell lines.
    Biochemical pharmacology, 1994, Nov-16, Volume: 48, Issue:10

    Topics: Affinity Labels; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Biological Transport; Cell Membrane; Cell Nucleus; Clone Cells; Colonic Neoplasms; Daunorubicin; Dihydropyridines; DNA Topoisomerases, Type II; Drug Resistance, Multiple; Fluorescence; Humans; Idarubicin; Tumor Cells, Cultured

1994
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivatives.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:3

    Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Gene Expression; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured

1993
D-verapamil downmodulates P170-associated resistance to doxorubicin, daunorubicin and idarubicin.
    Anti-cancer drugs, 1993, Volume: 4, Issue:2

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Survival; Colonic Neoplasms; Daunorubicin; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Idarubicin; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Tumor Cells, Cultured; Verapamil

1993
Immunochemotherapy of human colon carcinoma xenografts in nude mice using combinations of idarubicin-monoclonal antibody conjugates.
    Immunology and cell biology, 1993, Volume: 71 ( Pt 3)

    Topics: Animals; Antibodies, Monoclonal; Colonic Neoplasms; Humans; Idarubicin; Mice; Mice, Nude; Neoplasm Transplantation; Remission Induction; Transplantation, Heterologous; Tumor Cells, Cultured

1993
A comparison of the modulation of antiblastics cytotoxicity by verapamil and dipyridamole in a human colon carcinoma cell line.
    International journal of oncology, 1999, Volume: 15, Issue:1

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Colonic Neoplasms; Cyclophosphamide; Dipyridamole; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Idarubicin; Mitoxantrone; Neoplasm Proteins; Teniposide; Tumor Cells, Cultured; Verapamil; Vinblastine

1999